B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

BCL2L11

MOLECULAR TARGET

BCL2 like 11

UniProt: O43521NCBI Gene: 100181 compounds

BCL2L11 (BCL2 like 11) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting BCL2L11

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Anisomycin1.102

About BCL2L11 as a Drug Target

BCL2L11 (BCL2 like 11) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented BCL2L11 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

BCL2L11 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.